hypocretin modulators (Stanford/Michigan/Albert Einstein)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehypocretin modulators (Stanford/Michigan/Albert Einstein)
Drug Alias Namehypocretin agonists/antagonists (Neurocrine)orexin modulators (Stanford/Michigan/Albert Einstein)sleep disorder therapeutics (Neurocrine)orexin/hypocretin modulators (Neurocrine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor modulators
TargetsOrexin receptor
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford UniversityUniversity Of MichiganAlbert Einstein College Of Medicine Inc +[4] 
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A